Shares in Precipio Inc (NASDAQ:PRPO) added over 65% to $20.07 on Wednesday after announcing a multi-country agrement with Clearbridge Health before the bell.
It is to provide the firm's ICE COLD-PCR (ICP) technology in CBH's network of laboratories, serving patients in more than a dozen countries throughout Asia, including China, India, Taiwan, South Korea, Singapore, Malaysia, Indonesia, and Australia.
The deal is expected to significantly increase Precipio's footprint in the Asian market.
Jeremy Yee, chief executive at Clearbridge Health, said: "Precipio's platform of advanced technologies and specialized expertise and diagnostics will be well received by our network of physicians and patients, who are eager to gain access to these important tools.
"We are looking forward to working with the team at Precipio to bring the highest level of care to patients within our network."